deltatrials
Completed PHASE1 NCT00014248

Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors

A Phase I Study And Pharmacokinetics Of Adenosine 5'- Triphosphate (ATP) When Administered By Intravenous Infusion On A Multiple Weekly Dose Schedule To Patients With Advanced Malignancies (Solid Tumors)

Sponsor: Dartmouth-Hitchcock Medical Center

Conditions Cachexia Unspecified Adult Solid Tumor, Protocol Specific
Interventions adenosine triphosphate quality-of-life assessment
Updated 6 times since 2017 Last updated: Mar 15, 2013 Started: Oct 31, 2000 Primary completion: Nov 30, 2002

A PHASE1 clinical study on Cachexia and Unspecified Adult Solid Tumor, Protocol Specific, this trial is completed. The trial is conducted by Dartmouth-Hitchcock Medical Center and has accumulated 6 data snapshots since 2000. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Oct 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dartmouth-Hitchcock Medical Center
  • National Cancer Institute (NCI)
Data source: Dartmouth-Hitchcock Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Lebanon, United States